http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-2011010929-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_116c851e729089df9a427027272fa290 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-407 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-77 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-08 |
| filingDate | 2010-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36bd7a8da44be284d4f3241577256733 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e4f6fe836add27c2a6f8007da2a545f |
| publicationDate | 2011-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | MX-2011010929-A |
| titleOfInvention | DERIVATIVES OF N- [7-AZA-BICICLO [2.2.1] HEPT-1-IL) -ARIL-METHYL] -BENZAMI DA, ITS PREPARATION AND ITS USE IN THERAPEUTICS. |
| abstract | Compounds of formula (I) wherein: R represents a hydrogen atom or a group selected from the alkyl groups of 1 to 6 carbon atoms, cycloalkyl of 3 to 7 carbon atoms, optionally substituted with one or more groups independently selected from yes among the fluorine atom, the cycloalkyl groups of 3 to 7 carbon atoms, alkenyl of 2 to 4 carbon atoms, phenyl, alkoxy of 1 to 6 carbon atoms, hydroxy; the phenyl group is optionally substituted with one or more alkoxy groups of 1 to 6 carbon atoms; R1 represents a phenyl group optionally substituted with one or more substituents independently selected from each other among halogen atoms, alkyl groups of 1 to 6 carbon atoms, alkoxy of 1 to 6 carbon atoms, haloalkyl of 1 to 6 atoms carbon, hydroxy, haloalkoxy of 1 to 6 carbon atoms, alkylthio of 1 to 6 carbon atoms, alkyl of 1 to 6 carbon atoms-SO2, R2 represents one or more substituents selected from the hydrogen atom, halogen atoms, halo-alkyl groups of 1 to 6 carbon atoms, alkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 7 carbon atoms, cycloalkyl of 3 to 7 carbon atoms alkyl of 1 to 3 carbon atoms , alkoxy of 1 to 6 carbon atoms, alkylthio of 1 to 6 carbon atoms, alkyl of 1 to 6 carbon atoms-SO2 in the form of base or salt addition to an acid. Use in therapeutic and synthetic procedure. |
| priorityDate | 2009-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 33.